#mced tests

Discover 2 curated intelligence briefings related to this specific topic.

The End of the Waiting Game: How MCEDs are Redefining Cancer Detection
Health & Medicine

The End of the Waiting Game: How MCEDs are Redefining Cancer Detection

The oncology landscape is undergoing a seismic shift as multi-cancer early detection (MCED) tests move from experimental research to regulatory milestones. With the market projected to hit $21.4 billion by 2034, the 'wait and see' era of diagnosis is being replaced by high-sensitivity liquid biopsies.

Read Analysis
Liquid Biopsies Are Racing to Outrun the Early-Onset Cancer Spike
Health & Medicine

Liquid Biopsies Are Racing to Outrun the Early-Onset Cancer Spike

As cancer rates climb among adults under 50, Multi-Cancer Early Detection tests are pivoting from experimental curiosity to clinical contenders. But can a methylation signal truly replace the gold standard of invasive screening?

Read Analysis